Benjamin Paluch

Stock Analyst at Roth MKM

(1.31)

# 3,620

Out of 5,163 analysts

3

Total ratings

33.33%

Success rate

0.8%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$64.29	+1.10%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$7.14	+138.10%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$2.60	+284.62%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $64.29

Upside: +1.10%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $7.14

Upside: +138.10%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $2.60

Upside: +284.62%